SUPN CFO James P. Kelly resigns; Timothy C. Dec appointed as new CFO

SUPERNUS PHARMACEUTICALS, INC.

James P. Kelly resigns as EVP & CFO effective August 13, 2021 to join another company.
Timothy C. Dec appointed SVP & CFO effective August 23, 2021; over 35 years experience, most recently CFO of OpGen.
Dec receives $375,000 annual base salary, 40% target bonus prorated first year, and 85,000 options vesting over 4 years.
Dec enters Executive Retention Agreement with severance payments and accelerated vesting upon change in control.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James P. Kelly

Executive Vice-President and Chief Financial Officer

SUPN · SUPERNUS PHARMACEUTICALS, INC.

Effective: 2021-08-13
Successor: Timothy C. Dec
Filed: July 29, 2021, 7:59 PM ET

On July 23, 2021, James P. Kelly, Executive Vice-President and Chief Financial Officer, notified Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) of his resignation from the Company to join another company.

Appointed

Timothy C. Dec

Senior Vice-President and Chief Financial Officer

SUPN · SUPERNUS PHARMACEUTICALS, INC.

Effective: 2021-08-23
Filed: July 29, 2021, 7:59 PM ET

On July 27, 2021, the Company appointed Timothy C. Dec to the position of Senior Vice-President and Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

James P. Kelly resigned as Executive Vice-President and Chief Financial Officer at SUPERNUS PHARMACEUTICALS, INC..

Action: resigned
Role: Executive Vice-President and Chief Financial Officer

Exact text from the filing

On July 23, 2021, James P. Kelly, Executive Vice-President and Chief Financial Officer, notified Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) of his resignation from the Company to join another company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Timothy C. Dec was appointed as Senior Vice-President and Chief Financial Officer at SUPERNUS PHARMACEUTICALS, INC..

Action: appointed
Role: Senior Vice-President and Chief Financial Officer

Exact text from the filing

On July 27, 2021, the Company appointed Timothy C. Dec to the position of Senior Vice-President and Chief Financial Officer.

View on SEC.gov

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-21-097603

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.